News Flaggemelding Staff August 22, 2025 Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA. Iframe sync Post navigation Previous: Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceNext: Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP) More Stories Healthcare News Pharmaceutical Attorney General Rescheduling Order Claimed State Marijuana Controls Were Robust. Oklahoma Law Enforcement Tells a Different Story Staff November 15, 2026 News Grassroot Soccer Honors U.S. Soccer at 2026 Gala, Raising over $2 million for Adolescent Health Programs Staff November 15, 2026 Healthcare News Nutrition Personal Data Keto-Mojo Unveils World’s First Photoacoustic Breathalyzer, Advancing Non-Invasive Ketone Monitoring Staff November 15, 2026